HIMS & HERS HEALTH INC (HIMS) Stock Earnings & Estimates
USA - NYSE:HIMS - US4330001060 - Common Stock
35.58 USD
-1.4 (-3.79%)
35.2967 USD
-0.28 (-0.8%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 526.916M 93.81% | 872M 65.49% | 1.477B 69.33% | 2.388B 61.73% | 2.852B 19.43% | 3.369B 18.13% | 3.605B 7.01% | 4.129B 14.54% | 4.911B 18.94% | 5.823B 18.57% | 6.968B 19.66% | |
| EBITDA YoY % growth | -58.904M 39.67% | -16.493M 72.00% | 85.092M 615.93% | 324.79M 281.69% | 415.89M 28.05% | 521.15M 25.31% | 623.32M 19.60% | 778.84M 24.95% | 935.97M 20.17% | 1.145B 22.33% | 1.384B 20.87% | |
| EBIT YoY % growth | -66.378M 34.74% | -26.008M 60.82% | 68.004M 361.47% | 147.04M 116.22% | 234.3M 59.34% | 297.06M 26.79% | 401.18M 35.05% | 537.79M 34.05% | 641.49M 19.28% | 750.86M 17.05% | 822.35M 9.52% | |
| Operating Margin | -12.60% | -2.98% | 4.61% | 6.16% | 8.22% | 8.82% | 11.13% | 13.02% | 13.06% | 12.89% | 11.80% | |
| EPS YoY % growth | -0.32 42.75% | -0.11 65.63% | 0.54 590.91% | 0.60 11.88% | 0.81 34.10% | 1.02 25.33% | 2.41 137.08% | 3.09 28.39% | 3.97 28.38% | 5.10 28.53% | 6.55 28.40% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.07 -38.96% | 0.17 -15.00% | 0.27 60.50% | 0.24 303.75% | 0.27 302.55% | 0.32 86.00% | 0.44 60.75% | 0.19 -20.00% | 0.26 -5.66% |
| Revenue Q2Q % growth | 631.5M 31.25% | 665.13M 13.50% | 683.87M 25.52% | 709.92M 18.52% | 769.05M 21.78% | 771.07M 15.93% | 761.82M 11.40% | 784.66M 10.53% | 854.56M 11.12% |
| EBITDA Q2Q % growth | 66.277M 66.33% | 89.435M 35.10% | 104.75M 102.63% | 103.76M 90.09% | 115.66M 74.51% | 132.9M 48.60% | 143.61M 37.10% | 128.61M 23.95% | 143.02M 23.66% |
| EBIT Q2Q % growth | 17.455M -23.31% | 41.229M -28.82% | 70.658M 114.41% | 62.933M 246.24% | 74.902M 329.11% | 61.2M 48.44% | 86.496M 22.42% | 35.292M -43.92% | 47.838M -36.13% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.06 -81.25% | 0.11 | -0.05 | -43.53% |
| Q2 2025 Q2Q % growth | 0.17 183.33% | 0.15 | 0.02 | 10.29% |
| Q1 2025 Q2Q % growth | 0.20 300.00% | 0.12 | 0.08 | 62.17% |
| Q4 2024 Q2Q % growth | 0.11 1,000.00% | 0.11 | 0.00 | 4.62% |
| Q3 2024 Q2Q % growth | 0.32 900.00% | 0.04 | 0.28 | 666.87% |
| Q2 2024 Q2Q % growth | 0.06 300.00% | 0.04 | 0.02 | 37.66% |
| Q1 2024 Q2Q % growth | 0.05 200.00% | 0.01 | 0.04 | 308.50% |
| Q4 2023 Q2Q % growth | 0.01 120.00% | -0.02 | 0.03 | 152.29% |
| Q3 2023 Q2Q % growth | -0.04 55.56% | -0.03 | -0.01 | -24.77% |
| Q2 2023 Q2Q % growth | -0.03 70.00% | -0.06 | 0.03 | 45.82% |
| Q1 2023 Q2Q % growth | -0.05 37.50% | -0.07 | 0.02 | 31.37% |
| Q4 2022 Q2Q % growth | -0.05 66.67% | -0.07 | 0.02 | 26.47% |
| Q3 2022 Q2Q % growth | -0.09 -13.92% | -0.10 | 0.01 | 13.49% |
| Q2 2022 Q2Q % growth | -0.10 -233.33% | -0.10 | 0.00 | 3.57% |
| Q1 2022 Q2Q % growth | -0.08 73.33% | -0.07 | -0.01 | -10.08% |
| Q4 2021 Q2Q % growth | -0.15 -114.29% | -0.07 | -0.08 | -102.84% |
| Q3 2021 Q2Q % growth | -0.08 | -0.06 | -0.02 | -25.59% |
| Q2 2021 Q2Q % growth | -0.03 | -0.08 | 0.05 | 64.24% |
| Q1 2021 Q2Q % growth | -0.30 | -0.11 | -0.19 | -180.78% |
| Q4 2020 Q2Q % growth | -0.07 | -0.16 | 0.09 | 57.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 598.976M 49.16% | 591.85M | 7.126M | 1.20% |
| Q2 2025 Q2Q % growth | 544.833M 72.61% | 562.65M | -17.817M | -3.17% |
| Q1 2025 Q2Q % growth | 586.01M 110.67% | 548.97M | 37.04M | 6.75% |
| Q4 2024 Q2Q % growth | 481.139M 95.45% | 479.72M | 1.419M | 0.30% |
| Q3 2024 Q2Q % growth | 401.556M 77.13% | 389.85M | 11.706M | 3.00% |
| Q2 2024 Q2Q % growth | 315.648M 51.82% | 305.94M | 9.708M | 3.17% |
| Q1 2024 Q2Q % growth | 278.171M 45.81% | 275.79M | 2.381M | 0.86% |
| Q4 2023 Q2Q % growth | 246.169M 47.23% | 251.38M | -5.211M | -2.07% |
| Q3 2023 Q2Q % growth | 226.699M 56.52% | 224.45M | 2.249M | 1.00% |
| Q2 2023 Q2Q % growth | 207.912M 83.08% | 209.06M | -1.148M | -0.55% |
| Q1 2023 Q2Q % growth | 190.77M 88.30% | 182.66M | 8.11M | 4.44% |
| Q4 2022 Q2Q % growth | 167.203M 97.41% | 164.39M | 2.813M | 1.71% |
| Q3 2022 Q2Q % growth | 144.836M 95.27% | 132.95M | 11.886M | 8.94% |
| Q2 2022 Q2Q % growth | 113.563M 87.11% | 105.96M | 7.603M | 7.18% |
| Q1 2022 Q2Q % growth | 101.314M 93.67% | 92.998M | 8.316M | 8.94% |
| Q4 2021 Q2Q % growth | 84.699M | 78.329M | 6.37M | 8.13% |
| Q3 2021 Q2Q % growth | 74.173M | 71.942M | 2.231M | 3.10% |
| Q2 2021 Q2Q % growth | 60.692M | 57.623M | 3.069M | 5.33% |
| Q1 2021 Q2Q % growth | 52.314M | 49.79M | 2.524M | 5.07% |
| Q4 2020 Q2Q % growth | 37.744M | -37.744M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -50.06% | -53.71% | -2.1% | -11.33% |
| Revenue | -1.58% | -2.15% | 0.04% | -0.17% |